摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-allyl-N'-(2-hydroxy-1,1-bis-hydroxymethyl-ethyl)-urea | 90222-25-6

中文名称
——
中文别名
——
英文名称
N-allyl-N'-(2-hydroxy-1,1-bis-hydroxymethyl-ethyl)-urea
英文别名
N-Allyl-N'-(2-hydroxy-1,1-bis-hydroxymethyl-aethyl)-harnstoff;1-[1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl]-3-prop-2-enylurea;1-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]-3-prop-2-enylurea
<i>N</i>-allyl-<i>N</i>'-(2-hydroxy-1,1-bis-hydroxymethyl-ethyl)-urea化学式
CAS
90222-25-6
化学式
C8H16N2O4
mdl
——
分子量
204.226
InChiKey
YVVSTNROKUIXFK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.2
  • 重原子数:
    14
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    102
  • 氢给体数:
    5
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • C-PHENYL GLYCITOL COMPOUND
    申请人:Kakinuma Hiroyuki
    公开号:US20100022460A1
    公开(公告)日:2010-01-28
    Provided is a novel C-phenyl glycitol compound that may serve as a prophylactic or therapeutic agent for diabetes by inhibiting both SGLT1 activity and SGLT2 activity, thereby exhibiting a glucose absorption suppression action and a urine glucose excretion action. A C-phenyl glycitol compound represented by Formula (I) below or a pharmaceutically acceptable salt thereof or a hydrate thereof wherein R 1 and R 2 are the same or different and represent a hydrogen atom, a hydroxyl group, a C 1-6 alkyl group, a C 1-6 alkoxy group or a halogen atom, R 3 is a hydrogen atom, a C 1-6 alkyl group, a C 1-6 alkoxy group or a halogen atom, Y is a C 1-6 alkylene group, —O—(CH 2 )n— (n is an integer of 1 to 4) or a C 2-6 alkenylene group, provided that when Z is —NHC(═NH)NH 2 or —NHCON(R B )R C , n is not 1, Z is —CONHR A , —NHC(═NH)NH 2 or —NHCON(R B )R C ,
    提供的是一种新型C-苯基甘露醇化合物,可以作为预防或治疗糖尿病的药物,通过抑制SGLT1活性和SGLT2活性,从而表现出抑制葡萄糖吸收和尿液葡萄糖排泄的作用。该化合物表示为以下式子(I)的C-苯基甘露醇化合物,或其药学上可接受的盐或水合物,其中R1和R2相同或不同,表示氢原子、羟基、C1-6烷基、C1-6烷氧基或卤素原子,R3表示氢原子、C1-6烷基、C1-6烷氧基或卤素原子,Y表示C1-6烷基、-O-(CH2)n-(n为1至4的整数)或C2-6烯基烷基,但当Z为-NHC(=NH)NH2或-NHCON(RB)RC时,n不为1,Z为CONHRA,-NHC(=NH)NH2或-NHCON(RB)RC。
  • C-PHENYL GLYCITOL COMPOUND FOR THE TREATMENT OF DIABETES
    申请人:TAISHO PHARMACEUTICAL CO., LTD
    公开号:EP2076503B1
    公开(公告)日:2013-07-17
  • US7973012B2
    申请人:——
    公开号:US7973012B2
    公开(公告)日:2011-07-05
  • Discovery of a potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor (TP0438836) for the treatment of type 2 diabetes
    作者:Shoichi Kuroda、Yohei Kobashi、Takahiro Oi、Hideaki Amada、Lisa Okumura-Kitajima、Fusayo Io、Koji Yamamto、Hiroyuki Kakinuma
    DOI:10.1016/j.bmcl.2018.09.035
    日期:2018.12
    The design and synthesis of a novel class of low-absorbable SGLT1 inhibitors are described. To achieve low absorption in the new series, we performed an optimization study based on a strategy to increase TPSA. Fortunately, the optimization of an aglycon moiety and a side chain of the distal aglycon moiety led to the identification of compound 30b as a potent and low-absorbable SGLT1 inhibitor. Compound 30b showed a desirable PK profile in Sprague-Dawley (SD) rats and a favorable glucose-lowering effect in diabetic rats.
  • Notes - Reaction of Isocyanates with Tris-(hydroxymethyl) aminomethane
    作者:Roy Neville
    DOI:10.1021/jo01099a607
    日期:1958.5
查看更多